Infliximab Treatment in a Patient with Systemic Sclerosis Associated with Lung Fibrosis and Pulmonary Hypertension

By  

Respiration, Vol. 75, Iss. 3, 2005-12 ,pp. : 346-349

Karger

Access to resources Recommend Favorite

Identification of Cadherin 11 as a Mediator of Dermal Fibrosis and Possible Role in Systemic Sclerosis

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 4, 2014-04 ,pp. : 1010-1021

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systemic sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 45, Iss. 2, 2018-02 ,pp. : 128-138

John Wiley & Sons Inc

Access to resources Recommend Favorite

Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis

By Noda Shinji   Asano Yoshihide   Takahashi Takehiro   Akamata Kaname   Aozasa Naohiko   Taniguchi Takashi   Ichimura Yohei   Toyama Tetsuo   Sumida Hayakazu   Kuwano Yoshihiro   Yanaba Koichi   Tada Yayoi   Sugaya Makoto   Kadono Takafumi   Sato Shinichi  

British Journal of Rheumatology , Vol. 52, Iss. 5, 2013-05 ,pp. : 790-799

Oxford University Press

Access to resources Recommend Favorite

The Control of Fibrosis in Systemic Sclerosis: A Strategy Involving Extracellular Matrix, Cytokines, and Growth Factors

By  

THE JOURNAL OF DERMATOLOGY, Vol. 21, Iss. 1, 1994-01 ,pp. : 1-4

John Wiley & Sons Inc

Access to resources Recommend Favorite